International Antiaging Systems
 Welcome to IAS
Contact Us
 Product
 Further Reading
 Miscellaneous
Online Store A-Z Product List eNews Special Offers
 Reboxetine

Reboxetine focuses your mind & lightens your mood

Reboxetine is an anti-depressant with a unique group of actions that tackle anxiety and stimulate the mind

Reboxetine is an anti-depressant known as a selective noradrenaline re-uptake inhibitor (SNRI). When depression occurs there may be a decreased amount of a chemical called noradrenaline released from nerve cells in the brain. A release of noradrenaline acts to lighten mood. So when noradrenaline is reabsorbed into the nerve cells, it no longer can affect mood.

Reboxetine works by preventing this re-absorption of noradrenaline back into the nerve cells. Therefore, it helps prolong the mood-lightening effect of any released noradrenaline, which helps relieve depression.

Elderly people suffering from low mood, sleep disturbances, low energy levels and poor concentration could benefit from Reboxetine. As the elderly are particularly susceptible to the potential side effects of current antidepressants (due to age-related physiologic changes) Reboxetine may suit them better.

Studies found that patients felt "much" to "very much" improved by Reboxetine. It was well tolerated by the majority of patients and efficacy outweighed side effects in 75% of patients.

As a selective noradrenaline reuptake inhibitor, Reboxetine has been found to be an effective and safe anti-depressant. Furthermore, Reboxetine restores a patients' social functioning, producing a better quality of remission than fluoxetine.

Reboxetine can also be used as a stimulant. In studies with narcolepsy (uncontrolled daytime sleeping) Reboxetine was noted to exert stimulant and anticataplectic effects.

Dosage:
Initial dose is 4mg once or twice a day.

Side effects:
Headache, dry mouth, urinary hesitance, constipation, early awakening.

Caution:
Like most anti-depressants, this drug could interfere with other anti-depressants, particularly MAO inhibitors (including Gerovital-H3) and also with noradrenaline enhancers, such as Adrafinil and Modafinil, and therefore any combined use must only take place under the guidance of a physician. Reboxetine reduce your ability to drive or operate machinery safely. Do not drive or operate machinery until you know how this medicine affects you and you are sure it won't affect your performance.

To see the full ingredients in Edronax, and its "approved" uses/ dosages, as well as potential side effects and contraindications please click here.

To see the full ingredients in Davedax, and its "approved" uses/ dosages, as well as potential side effects and contraindications please click here.

To read articles about Reboxetine please click here.

To read our E-News articles on Reboxetine products please click here









Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 2.5 License.

Reboxetine

Customers who have bought Reboxetine have also been interested in the following items:

Milnacipran
Modafinil
Modafinil
Adrafinil
Adrafinil